Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03728088
Other study ID # B670201628799
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date September 1, 2016
Est. completion date June 2025

Study information

Verified date December 2023
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study consists of an analysis of the communication styles and attitudes towards risk and uncertainty (i.e. non-technical attributes) in a surgical population with varying clinical experience. The study aims to investigate the differences and specific patterns in non-technical attributes that may be discerned in these groups and how these non technical attributes develop throughout surgical training.


Description:

This study evaluated the communication styles and attitudes towards risk and uncertainty in a population of surgical candidates (pre- and postgraduates), surgical trainees and surgical staff members, from the specialties of general surgery, orthopedics, urology and plastic surgery. After signing informed consent, participants complete an on-line questionnaire, which contains a set of validated tools. Initially, a cross-sectional analysis of the non-technical attributes will be conducted, to identify any patters, similarities or differences between participant groups. The study hypothesis is that significant differences can be observed in participant attributes, which relate to their clinical experience. Additionally, surgical candidates who agree to participate in this study and are accepted for a surgical training in either general surgery, orthopaedics, urology or plastic surgery, will be invited to repeat the questionnaire at a 2-year interval, to investigate the evolution of their non-technical attributes throughout their training and to identify general patterns.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 120
Est. completion date June 2025
Est. primary completion date June 2024
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Participant is part of any of the following groups: - Applicant for surgical training in general surgery, orthopedics, urology or plastic surgery. - Trainee in general surgery, orthopedics, urology, plastic surgery. - Staff in general surgery, orthopedics, urology, plastic surgery. - Participant is active at Ghent University Hospital or an affiliated training hospital. No exclusion criteria apply to this study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Rating scales concerning non-technical attributes


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Ghent

Outcome

Type Measure Description Time frame Safety issue
Primary Participant communication styles Communication Styles Inventory-96 scale:Subdomains: Expressiveness (range: 1-5); Preciseness (range: 1-5); Verbal aggressiveness (range: 1-5); Questioningness (range: 1-5); Emotionality (range: 1-5); Impression manipulativeness (range: 1-5) Rating scale is completed by all groups on study inclusion, after signing informed consent.
Primary Participant attitudes towards uncertainty Physicians' Reactions to Uncertainty (PRU) scale: Anxiety due to uncertainty (Range: 5-30
); Concern about bad outcomes (3-18); Reluctance to disclose uncertainty to patients (Range: 5-30); Reluctance to disclose mistakes to physicians (Range 2-12)
Rating scale is completed by all groups on study inclusion, after signing informed consent. For the candidate group, this measure is repeated on a selection day during the surgical selection process, +- 1 - 2 months after study inclusion
Primary Participant attitudes towards taking risks Physicians' risk attitude (PRA) Scale (Range: 2-12) Rating scale is completed by all groups on study inclusion, after signing informed consent. For the candidate group, this measure is repeated on a selection day during the surgical selection process, +- 1 - 2 months after study inclusion
Secondary Participant perceived actual health status Short Form-36 scale (Range: 10-50) Rating scale is completed by all groups on study inclusion, after signing informed consent.
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1